-
1
-
-
0033984573
-
Preoperative radiochemotherapy in rectal cancer: Long-term results of a phase II trial
-
Bosset J.F., Magnin V., Maingon P., et al.: Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial. Int. J. Radiat. Oncol. Biol. Phys. 46: 323-327, 2000.
-
(2000)
Int. J. Radiat. Oncol. Biol. Phys
, vol.46
, pp. 323-327
-
-
Bosset, J.F.1
Magnin, V.2
Maingon, P.3
-
2
-
-
0029057685
-
Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum
-
Chari R.S., Tyler D.S., Anscher M.S., et al.: Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann. Surg. 221: 778-786, 1995.
-
(1995)
Ann. Surg
, vol.221
, pp. 778-786
-
-
Chari, R.S.1
Tyler, D.S.2
Anscher, M.S.3
-
3
-
-
0028115401
-
Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer
-
Minsky B., Cohen A.M., Enker W., et al.: Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer 73: 273-280, 1994.
-
(1994)
Cancer
, vol.73
, pp. 273-280
-
-
Minsky, B.1
Cohen, A.M.2
Enker, W.3
-
4
-
-
0029093508
-
Preoperative infusional chemoradiation therapy for stage T3 rectal cancer
-
Rich T.A., Skibber J.M., Ajani J.A., et al.: Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 32:1025-1029, 1995.
-
(1995)
Int. J. Radiat. Oncol. Biol. Phys
, vol.32
, pp. 1025-1029
-
-
Rich, T.A.1
Skibber, J.M.2
Ajani, J.A.3
-
5
-
-
31844451549
-
Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: Effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival
-
Wiltshire K.L., Ward I.G., Swallow C., et al.: Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival. Int. J. Radiat. Oncol. Biol. Phys. 64:709-16, 2006.
-
(2006)
Int. J. Radiat. Oncol. Biol. Phys
, vol.64
, pp. 709-716
-
-
Wiltshire, K.L.1
Ward, I.G.2
Swallow, C.3
-
6
-
-
0028136295
-
Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery
-
O'Connell M.J., Martenson J.A., Wieand H.S., et al.: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N. Engl. J. Med. 331: 502-507, 1994.
-
(1994)
N. Engl. J. Med
, vol.331
, pp. 502-507
-
-
O'Connell, M.J.1
Martenson, J.A.2
Wieand, H.S.3
-
7
-
-
0029020530
-
Concomitant radiochemo-therapy in rectal cancer: Methodology and indications
-
Valentini V., Luzi S., Mantini G., Turriziani A., Cellini N.: Concomitant radiochemo-therapy in rectal cancer: methodology and indications. Rays 20: 90-111, 1995.
-
(1995)
Rays
, vol.20
, pp. 90-111
-
-
Valentini, V.1
Luzi, S.2
Mantini, G.3
Turriziani, A.4
Cellini, N.5
-
8
-
-
0031471150
-
Systemic treatment options in advanced colorectal cancer: Perspectives on combination 5-fluorouracil plus leucovorin
-
Grem J.L.: Systemic treatment options in advanced colorectal cancer: perspectives on combination 5-fluorouracil plus leucovorin. Semin. Oncol. 24 (Suppl. 18): 8-18, 1997.
-
(1997)
Semin. Oncol
, vol.24
, Issue.SUPPL. 18
, pp. 8-18
-
-
Grem, J.L.1
-
9
-
-
0032127244
-
Design of a novel oral fluoropyrimidinecarbamate capecitabine, wich generates 5-fluorouracilselectively in tumours by enzymes concentrated in human liver and cancer tissue
-
Miwa M., Ura M., Nishida M., et al.: Design of a novel oral fluoropyrimidinecarbamate capecitabine, wich generates 5-fluorouracilselectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur. J. Cancer 34: 1274-1281, 1998.
-
(1998)
Eur. J. Cancer
, vol.34
, pp. 1274-1281
-
-
Miwa, M.1
Ura, M.2
Nishida, M.3
-
10
-
-
0032695102
-
X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenograft
-
Sawada N., Ishikawa T., Sekiguchi F., Tanaka Y., Ishitsuka H.: X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenograft. Clin. Cancer Res. 5: 2948-2953, 1999.
-
(1999)
Clin. Cancer Res
, vol.5
, pp. 2948-2953
-
-
Sawada, N.1
Ishikawa, T.2
Sekiguchi, F.3
Tanaka, Y.4
Ishitsuka, H.5
-
11
-
-
0036177692
-
Future treatment options with capecitabine in solid tumors
-
Wilke H.: Future treatment options with capecitabine in solid tumors. Eur. J. Cancer 38 (Suppl. 2): 21-25, 2002.
-
(2002)
Eur. J. Cancer
, vol.38
, Issue.SUPPL. 2
, pp. 21-25
-
-
Wilke, H.1
-
12
-
-
0035690103
-
Capecitabine: A review of its use in the treatment of advanced or metastatic colorectal cancer
-
McGavin J.K., Goa K.L.: Capecitabine: a review of its use in the treatment of advanced or metastatic colorectal cancer. Drugs 61:2309-2326, 2001.
-
(2001)
Drugs
, vol.61
, pp. 2309-2326
-
-
McGavin, J.K.1
Goa, K.L.2
-
13
-
-
33646450317
-
Capecitabine in the treatment of colorectal cancer
-
O'Neill V.J., Cassidy J.: Capecitabine in the treatment of colorectal cancer. Future Oncol. 1:183-90, 2005.
-
(2005)
Future Oncol
, vol.1
, pp. 183-190
-
-
O'Neill, V.J.1
Cassidy, J.2
-
14
-
-
0034745284
-
The Xeloda Colorectal Cancer Study Group: Capecitabine (Xeloda) improves medical resource use compared with 5 fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma
-
Twelves C., Boyer M., Findlay M., et al. : The Xeloda Colorectal Cancer Study Group: Capecitabine (Xeloda) improves medical resource use compared with 5 fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma. Eur. J. Cancer 37: 597-604, 2001.
-
(2001)
Eur. J. Cancer
, vol.37
, pp. 597-604
-
-
Twelves, C.1
Boyer, M.2
Findlay, M.3
-
15
-
-
0035871538
-
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study
-
Hoff P.M., Ansari M., Batist G., et al.: Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J. Clin. Oncol. 19: 2282-2292, 2001.
-
(2001)
J. Clin. Oncol
, vol.19
, pp. 2282-2292
-
-
Hoff, P.M.1
Ansari, M.2
Batist, G.3
-
16
-
-
2442535083
-
Intensity modulate radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer
-
Ben-Josef E., Shields A.F., Vaishanpayan U., et al.: Intensity modulate radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 59: 454-459, 2004.
-
(2004)
Int. J. Radiat. Oncol. Biol. Phys
, vol.59
, pp. 454-459
-
-
Ben-Josef, E.1
Shields, A.F.2
Vaishanpayan, U.3
-
17
-
-
0036643954
-
A single institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies
-
Vaishampayan U.N., Ben-Josef E., Philip P.A., et al.: A single institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies. Int. J. Radiat. Oncol. Biol. Phys. 53, 675-679, 2002.
-
(2002)
Int. J. Radiat. Oncol. Biol. Phys
, vol.53
, pp. 675-679
-
-
Vaishampayan, U.N.1
Ben-Josef, E.2
Philip, P.A.3
-
18
-
-
33644968733
-
Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine
-
Lee H.S., Choi Y., Hur W.J., et al. : Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: adjuvant 5-FU/cisplatin and chemoradiation with capecitabine. World J. Gastroenterol. 12:603-7, 2006.
-
(2006)
World J. Gastroenterol
, vol.12
, pp. 603-607
-
-
Lee, H.S.1
Choi, Y.2
Hur, W.J.3
-
19
-
-
0037827307
-
Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer
-
Souglakos J., Androulakis N., Mavroudis D., et al.: Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 56: 1284-1287, 2003.
-
(2003)
Int. J. Radiat. Oncol. Biol. Phys
, vol.56
, pp. 1284-1287
-
-
Souglakos, J.1
Androulakis, N.2
Mavroudis, D.3
-
20
-
-
31844452408
-
A phase I study of concurrent radiotherapy and capecitabine as adjuvant treatment for operable rectal cancer
-
Jin J., Li Y.X., Liu Y.P., et al. : A phase I study of concurrent radiotherapy and capecitabine as adjuvant treatment for operable rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 64:725-729, 2006.
-
(2006)
Int. J. Radiat. Oncol. Biol. Phys
, vol.64
, pp. 725-729
-
-
Jin, J.1
Li, Y.X.2
Liu, Y.P.3
-
21
-
-
33645100321
-
Capecitabine chemoradiation for rectal cancer after curative surgery
-
Bajetta E., Beretta E., Di Bartolomeo M., et al.: Capecitabine chemoradiation for rectal cancer after curative surgery. J. Chemother. 18:85-9, 2006.
-
(2006)
J. Chemother
, vol.18
, pp. 85-89
-
-
Bajetta, E.1
Beretta, E.2
Di Bartolomeo, M.3
-
22
-
-
0142041932
-
Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: Rationale, preliminary results and perspectives
-
Corvò R., Pastrone I., Scolaro T., Mercenaro M., Berretta L., Chiara S. : Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives. Tumori 89: 361-367, 2003.
-
(2003)
Tumori
, vol.89
, pp. 361-367
-
-
Corvò, R.1
Pastrone, I.2
Scolaro, T.3
Mercenaro, M.4
Berretta, L.5
Chiara, S.6
-
23
-
-
0036804343
-
Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer
-
Kim J.S., Kim J., Cho M.J., Song K.S., Yoon W.H.: Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 54: 403-408, 2002.
-
(2002)
Int. J. Radiat. Oncol. Biol. Phys
, vol.54
, pp. 403-408
-
-
Kim, J.S.1
Kim, J.2
Cho, M.J.3
Song, K.S.4
Yoon, W.H.5
-
24
-
-
0034176245
-
-
Trotti A, Byhardt R, Stetz J, et al, Common toxicity criteria: version 2.0. An improved reference for grading the acute effects on cancer treatment: impact on radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 47: 13-47, 2000
-
Trotti A., Byhardt R., Stetz J., et al.: Common toxicity criteria: version 2.0. An improved reference for grading the acute effects on cancer treatment: impact on radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 47: 13-47, 2000.
-
-
-
-
25
-
-
0028305674
-
Pathologic assessment of tumor regression after preoperative chemoradiotherapy for esophageal carcinoma
-
Mandard A.M., Dalibard F., Manyard J.C., et al.: Pathologic assessment of tumor regression after preoperative chemoradiotherapy for esophageal carcinoma. Cancer 73: 2680-2686, 1994.
-
(1994)
Cancer
, vol.73
, pp. 2680-2686
-
-
Mandard, A.M.1
Dalibard, F.2
Manyard, J.C.3
-
26
-
-
33845382806
-
Non parametric extimation from incomplete observations
-
Kaplan E.L., Meier P.: Non parametric extimation from incomplete observations. J. Am. Stat. Assoc. 53: 457-481, 1958.
-
(1958)
J. Am. Stat. Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
27
-
-
24944534960
-
Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate
-
Folkesson J., Birgisson H., Pahlman L., Cedermark B., Glimelius B., Gunnarsson U.: Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J. Clin. Oncol. 23: 5644-5650, 2005.
-
(2005)
J. Clin. Oncol
, vol.23
, pp. 5644-5650
-
-
Folkesson, J.1
Birgisson, H.2
Pahlman, L.3
Cedermark, B.4
Glimelius, B.5
Gunnarsson, U.6
-
28
-
-
0035975394
-
Dutch Colorectal Cancer Group: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
-
Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al.: Dutch Colorectal Cancer Group: preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N. Engl. J. Med. 345: 638-646, 2001.
-
(2001)
N. Engl. J. Med
, vol.345
, pp. 638-646
-
-
Kapiteijn, E.1
Marijnen, C.A.2
Nagtegaal, I.D.3
-
29
-
-
33644845287
-
Swedish Rectal Cancer Trial Group. Adverse effects of preoperative radiation therapy for rectal cancer: Long-term follow-up of the Swedish Rectal Cancer Trial
-
Birgisson H., Pahlman L., Gunnarsson U., Glimelius B.: Swedish Rectal Cancer Trial Group. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J. Clin. Oncol. 23:8697-705, 2005.
-
(2005)
J. Clin. Oncol
, vol.23
, pp. 8697-8705
-
-
Birgisson, H.1
Pahlman, L.2
Gunnarsson, U.3
Glimelius, B.4
-
30
-
-
25844523989
-
Polish Colorectal Study Group. Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: Results of a randomised trial: implication for subsequent local excision
-
Bujko K., Nowacki M.P, Nasierowska-Guttmejer A., et al.: Polish Colorectal Study Group. Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision. Radiother. Oncol. 2005 76:234-40.
-
(2005)
Radiother. Oncol
, vol.76
, pp. 234-240
-
-
Bujko, K.1
Nowacki, M.P.2
Nasierowska-Guttmejer, A.3
-
31
-
-
6044226542
-
-
Sauer R., Becker H., Hohenberger W., and German Rectal Cancer Study Group.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 351:1731-40, 2004.
-
Sauer R., Becker H., Hohenberger W., and German Rectal Cancer Study Group.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 351:1731-40, 2004.
-
-
-
-
32
-
-
24944499364
-
Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results-EORTC 22921
-
Bosset J.F., Calais G., Mineur L., et al.: Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921. J. Clin. Oncol. 23:5620-5627, 2005.
-
(2005)
J. Clin. Oncol
, vol.23
, pp. 5620-5627
-
-
Bosset, J.F.1
Calais, G.2
Mineur, L.3
-
33
-
-
30944457098
-
Pre-operative chemo-radiotherapy improves local control in T3-4 rectal cancers: Results of the FFCD 9203 randomized trial
-
Abstr
-
Gerard J., Romestaing P., Bonnetain F., et al. : Pre-operative chemo-radiotherapy improves local control in T3-4 rectal cancers: results of the FFCD 9203 randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 63 (Suppl. 1):S2 (Abstr.), 2005.
-
(2005)
Int. J. Radiat. Oncol. Biol. Phys
, vol.63
, Issue.SUPPL. 1
-
-
Gerard, J.1
Romestaing, P.2
Bonnetain, F.3
-
34
-
-
2942648695
-
Four decades of continuing innovation with fluorouracil: Current and future approaches to fluorouracil chemoradiation therapy
-
Rich T., Shepard RC., Mosley S.T.: Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy. J. Clin. Oncol. 22: 2214-2232, 2004.
-
(2004)
J. Clin. Oncol
, vol.22
, pp. 2214-2232
-
-
Rich, T.1
Shepard, R.C.2
Mosley, S.T.3
-
35
-
-
0344109583
-
Efficacy of intravenous continous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer
-
Meta-analysis Group in cancer
-
Meta-analysis Group in cancer: Efficacy of intravenous continous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J. Clin. Oncol. 16: 301-308, 1998.
-
(1998)
J. Clin. Oncol
, vol.16
, pp. 301-308
-
-
-
36
-
-
0031431131
-
5Fluorouracil (5FU) continuous intravenous infusion compared with bolus administration. Final results of a randomized trial in metastatic colorectal cancer
-
Rougier P., Pailloty B., LaPlanche A. , et al.: 5Fluorouracil (5FU) continuous intravenous infusion compared with bolus administration. Final results of a randomized trial in metastatic colorectal cancer. Eur. J. Cancer 33: 1789-1983, 1997
-
(1997)
Eur. J. Cancer
, vol.33
, pp. 1789-1983
-
-
Rougier, P.1
Pailloty, B.2
LaPlanche, A.3
-
37
-
-
21244497388
-
Capecitabine as adjuvant treatment for stage III colon cancer
-
Twelves C., Wong A., Nowacki M.P., et al.: Capecitabine as adjuvant treatment for stage III colon cancer. N. Engl. J. Med. 35:2696-704, 2005.
-
(2005)
N. Engl. J. Med
, vol.35
, pp. 2696-2704
-
-
Twelves, C.1
Wong, A.2
Nowacki, M.P.3
-
38
-
-
0030810428
-
Irradiation plus 5-fluorouracil: Cellular mechanisms of action and treatment schedule
-
Rich T.A.: Irradiation plus 5-fluorouracil: cellular mechanisms of action and treatment schedule. Semin. Radiat. Oncol. 7: 267-273, 1997.
-
(1997)
Semin. Radiat. Oncol
, vol.7
, pp. 267-273
-
-
Rich, T.A.1
-
39
-
-
31544483550
-
Pharmacoeconomic analysis of oral capecitabine in the adjuvant setting. Resuts from the X-ACT trial comparing capecitabine with i.v. 5-FU/LV in patients with Dukes'C colon cancer
-
Abstr
-
Douillard .JY., Twelves C., Mc Kendrick J.F., et al: Pharmacoeconomic analysis of oral capecitabine in the adjuvant setting. Resuts from the X-ACT trial comparing capecitabine with i.v. 5-FU/LV in patients with Dukes'C colon cancer. Ann. Oncol. 15 (Suppl. 3): s112 (Abstr.), 2004.
-
(2004)
Ann. Oncol
, vol.15
, Issue.SUPPL. 3
-
-
Douillard, J.Y.1
Twelves, C.2
Mc Kendrick, J.F.3
-
40
-
-
2342624007
-
Cost-benefit analysis of capecitabine versus 5-fluorouracil/leucovorin in the treatment of colorectal cancer in the Netherlands
-
Jansman F.G., Postma M.J., van Hartskamp D., Willemse P.H., Brouwers J.R.: Cost-benefit analysis of capecitabine versus 5-fluorouracil/leucovorin in the treatment of colorectal cancer in the Netherlands. Clin. Ther. 26: 579-589, 2004.
-
(2004)
Clin. Ther
, vol.26
, pp. 579-589
-
-
Jansman, F.G.1
Postma, M.J.2
van Hartskamp, D.3
Willemse, P.H.4
Brouwers, J.R.5
-
41
-
-
4444346434
-
Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advanced colorectal cancer
-
Abstr
-
James R., Bianco C., Farina C.: Savings in staff time as a result of switching from De Gramont to oral capecitabine for patients with advanced colorectal cancer. Eur. J. Cancer 39 (Suppl. 5): s83 (Abstr.), 2003.
-
(2003)
Eur. J. Cancer
, vol.39
, Issue.SUPPL. 5
-
-
James, R.1
Bianco, C.2
Farina, C.3
-
42
-
-
0031017851
-
Patient preferences for oral versus intravenous palliative chemotherapy
-
Liu G., Fransse E., Fitch M., Warner E. : Patient preferences for oral versus intravenous palliative chemotherapy. J. Clin. Oncol. 15:110-115, 1997.
-
(1997)
J. Clin. Oncol
, vol.15
, pp. 110-115
-
-
Liu, G.1
Fransse, E.2
Fitch, M.3
Warner, E.4
-
43
-
-
0036159485
-
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: A randomised crossover trial in advanced colorectal cancer
-
Borner M.M., Schoffski P., de Wit R., et al.: Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur. J. Cancer 38: 349-358, 2002.
-
(2002)
Eur. J. Cancer
, vol.38
, pp. 349-358
-
-
Borner, M.M.1
Schoffski, P.2
de Wit, R.3
-
44
-
-
0036787579
-
Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer
-
Dunst J., Reese T., Sutter T., et al.: Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J. Clin. Oncol. 20: 3983-3991, 2002.
-
(2002)
J. Clin. Oncol
, vol.20
, pp. 3983-3991
-
-
Dunst, J.1
Reese, T.2
Sutter, T.3
-
45
-
-
5044220099
-
A phase I trial of preoperative radiotherapy and capecitabine for locally advanced rectal cancer
-
Ngan S.Y.K., Michael M., Mackay J., et al. : A phase I trial of preoperative radiotherapy and capecitabine for locally advanced rectal cancer. Br. J. Cancer 91: 1019-1024, 2004.
-
(2004)
Br. J. Cancer
, vol.91
, pp. 1019-1024
-
-
Ngan, S.Y.K.1
Michael, M.2
Mackay, J.3
-
46
-
-
34247520247
-
Preoperative Capecitabine (X) chemoradiation is effective and well tolerated in patients with locally advanced rectal cancer (LARC): Findings from a phase I dose-escalation study
-
Abstr
-
Veerasarn V., Phronratanapongse P., Lorvidhaya V., et al.: Preoperative Capecitabine (X) chemoradiation is effective and well tolerated in patients with locally advanced rectal cancer (LARC): findings from a phase I dose-escalation study. Radiother. Oncol. 73 (Suppl. 1): s267 (Abstr.), 2004.
-
(2004)
Radiother. Oncol
, vol.73
, Issue.SUPPL. 1
-
-
Veerasarn, V.1
Phronratanapongse, P.2
Lorvidhaya, V.3
-
47
-
-
31544461568
-
Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: A multicentric phase II study
-
De Paoli A., Chiara S., Luppi G., et al.: Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann. Oncol. 17:246-51, 2006
-
(2006)
Ann. Oncol
, vol.17
, pp. 246-251
-
-
De Paoli, A.1
Chiara, S.2
Luppi, G.3
-
48
-
-
34247474038
-
Prospective phase II study of preoperative radiotherapy and oral capecitabine followed by total mesorectal excision (TME) in locally advanced rectal cancer
-
Abstr
-
Kim J.H., Park J.H., Choi E.K., et al.: Prospective phase II study of preoperative radiotherapy and oral capecitabine followed by total mesorectal excision (TME) in locally advanced rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 60 (Suppl. 1): s425 (Abstr.), 2004.
-
(2004)
Int. J. Radiat. Oncol. Biol. Phys
, vol.60
, Issue.SUPPL. 1
-
-
Kim, J.H.1
Park, J.H.2
Choi, E.K.3
-
49
-
-
24944563286
-
Capecitabine (C) chemoradiation (CRT) in the preoperative treatment of patients (pts) with rectal adenocarcinomas: A phase II GERCOR trial
-
Abstr
-
Dupuis B., Vie G., Lledo C., et al: Capecitabine (C) chemoradiation (CRT) in the preoperative treatment of patients (pts) with rectal adenocarcinomas: a phase II GERCOR trial. J. Clin. Oncol. 22 (Suppl. 14): s254 (Abstr.), 2004.
-
(2004)
J. Clin. Oncol
, vol.22
, Issue.SUPPL. 14
-
-
Dupuis, B.1
Vie, G.2
Lledo, C.3
-
50
-
-
34247469505
-
Altered fractionation chemoradiotherapy for locally advanced rectal cancer
-
Washington, Abstr
-
Zubyk S., Fuller C.D., Kahlenberg M.S., et al.: Altered fractionation chemoradiotherapy for locally advanced rectal cancer. Gastrointestinal Cancer Symposium, Washington 39 (Abstr.), 2004.
-
(2004)
Gastrointestinal Cancer Symposium
, pp. 39
-
-
Zubyk, S.1
Fuller, C.D.2
Kahlenberg, M.S.3
-
51
-
-
33644696400
-
Phase II study of capecitabine and concomitant boost radiotherapy (XRT) in patients (pts) with locally advanced rectal cancer (LARC)
-
s, Abstr
-
Lin .EH., Skibber J., Delcos M., et al.: Phase II study of capecitabine and concomitant boost radiotherapy (XRT) in patients (pts) with locally advanced rectal cancer (LARC). J. Clin. Oncol. 23, (Suppl. 1): s 3593 (Abstr.), 2005.
-
(2005)
J. Clin. Oncol
, vol.23
, Issue.SUPPL. 1
, pp. 3593
-
-
Lin, E.H.1
Skibber, J.2
Delcos, M.3
-
52
-
-
34247489887
-
-
Sefr R., Kocakova I., Penka I. et al.: Preoperative radiotherapy and oral capecitabine improve surgical results in patients with locally advanced mid-lower rectal cancer. Eur. J. Cancer Suppl 3/2: s201 (Abstr.), 2005.
-
Sefr R., Kocakova I., Penka I. et al.: Preoperative radiotherapy and oral capecitabine improve surgical results in patients with locally advanced mid-lower rectal cancer. Eur. J. Cancer Suppl 3/2: s201 (Abstr.), 2005.
-
-
-
-
53
-
-
4444302024
-
Phase-II-study of preoperative chemoradiation with capecitabine in rectal cancer
-
Dunst J., Reese T., Debus J. et al.: Phase-II-study of preoperative chemoradiation with capecitabine in rectal cancer. J. Clin. Oncol. 22 (Suppl. 14): s259, 2004.
-
(2004)
J. Clin. Oncol
, vol.22
, Issue.SUPPL. 14
-
-
Dunst, J.1
Reese, T.2
Debus, J.3
-
54
-
-
0032783898
-
Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer
-
Janjan N.A., Khoo V.S., Abbruzzese J., et al.: Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 44: 1027-1038, 1999.
-
(1999)
Int. J. Radiat. Oncol. Biol. Phys
, vol.44
, pp. 1027-1038
-
-
Janjan, N.A.1
Khoo, V.S.2
Abbruzzese, J.3
-
55
-
-
0043067010
-
The addition of continuous infusion of 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer
-
Crane C.H., Skibber J.N., Birnbaum E.H., et al. : The addition of continuous infusion of 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 57: 84-89, 2003.
-
(2003)
Int. J. Radiat. Oncol. Biol. Phys
, vol.57
, pp. 84-89
-
-
Crane, C.H.1
Skibber, J.N.2
Birnbaum, E.H.3
-
57
-
-
33744472470
-
Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil
-
Yerushalmi R., Idelevich E., Dror Y., et al. : Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil. J. Surg. Oncol. 93:529-33, 2006
-
(2006)
J. Surg. Oncol
, vol.93
, pp. 529-533
-
-
Yerushalmi, R.1
Idelevich, E.2
Dror, Y.3
-
58
-
-
33646236446
-
Neoadjuvant Chemoradiation with Capecitabine versus infusional 5-fluorouracil (5-FU) for locally advanced rectal cancer: A matched pair analysis
-
Abstr
-
Das P., Lin E.H., Bhatia S., et al: Neoadjuvant Chemoradiation with Capecitabine versus infusional 5-fluorouracil (5-FU) for locally advanced rectal cancer: a matched pair analysis. Int. J. Radiat. Oncol. Phys. 63 (Suppl.1): s164 (Abstr.), 2005.
-
(2005)
Int. J. Radiat. Oncol. Phys
, vol.63
, Issue.SUPPL.1
-
-
Das, P.1
Lin, E.H.2
Bhatia, S.3
-
59
-
-
33144459846
-
Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer
-
Kim J.S., Kim J.S., Cho M.J., Yoon W.H., Song K.S. :Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer. J. Korean Med. Sci. 21:52-7, 2006
-
(2006)
J. Korean Med. Sci
, vol.21
, pp. 52-57
-
-
Kim, J.S.1
Kim, J.S.2
Cho, M.J.3
Yoon, W.H.4
Song, K.S.5
-
60
-
-
29844435015
-
A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer
-
Glynne-Jones R., Sebag-Montefiore D., Maughan T.S., Falk S.J., McDonald A.C.: A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer. Ann. Oncol. 17: 50-56, 2006.
-
(2006)
Ann. Oncol
, vol.17
, pp. 50-56
-
-
Glynne-Jones, R.1
Sebag-Montefiore, D.2
Maughan, T.S.3
Falk, S.J.4
McDonald, A.C.5
-
61
-
-
20144375332
-
Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer
-
Hofheinz R.D., von Gerstemberg-Helldorf B., Wenz F., et al.: Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer. J. Clin. Oncol. 23: 1350-1357, 2005.
-
(2005)
J. Clin. Oncol
, vol.23
, pp. 1350-1357
-
-
Hofheinz, R.D.1
von Gerstemberg-Helldorf, B.2
Wenz, F.3
-
62
-
-
33645728850
-
Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: Results from a phase I/II study
-
Klautke G., Kuchenmeister U., Foitzik T., et al. : Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study. Br. J. Cancer. 94:976-81, 2006
-
(2006)
Br. J. Cancer
, vol.94
, pp. 976-981
-
-
Klautke, G.1
Kuchenmeister, U.2
Foitzik, T.3
-
63
-
-
28444461463
-
Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: The RadiOxCape study
-
Machiels J.P., Duck L., Honhon B., et al.: Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study. Ann. Oncol. 16:1898-905, 2005.
-
(2005)
Ann. Oncol
, vol.16
, pp. 1898-1905
-
-
Machiels, J.P.1
Duck, L.2
Honhon, B.3
-
64
-
-
33644846344
-
Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer
-
Chau I., Brown G., Cunningham D., et al.: Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J. Clin. Oncol. 24:668-74, 2006.
-
(2006)
J. Clin. Oncol
, vol.24
, pp. 668-674
-
-
Chau, I.1
Brown, G.2
Cunningham, D.3
-
65
-
-
25844442570
-
The multidisciplinary rectal cancer treatment: Main convergences, controversial aspects and investigational areas which support the need for an European Consensus
-
Valentini V., Glimelius B., Minsky BD., et al. : The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus. Radiother. Oncol. 76:241-50, 2005.
-
(2005)
Radiother. Oncol
, vol.76
, pp. 241-250
-
-
Valentini, V.1
Glimelius, B.2
Minsky, B.D.3
-
66
-
-
0041379454
-
Neoadjuvant radiochemotherapy treatment in locally advanced rectal adenocarcinoma
-
Carau B., Orrù. P. Orrù S., et al: Neoadjuvant radiochemotherapy treatment in locally advanced rectal adenocarcinoma. Tumori. 89 (Suppl.4): s7-8, 2003.
-
(2003)
Tumori
, vol.89
, Issue.SUPPL.4
-
-
Carau, B.1
Orrù, P.2
Orrù, S.3
|